Atlas Trials

Bioequivalence Study for Acarbose / Metformin FDC

Clinical trial NCT01728740 · COMPLETED

Trial details

NCT number
NCT01728740
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Type II
Start date
2012-09-01
Primary completion
2012-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.